Prognostic Impact of 18FDG-PET-CT Findings in Clinical Stage III and IIB Breast Cancer | Zendy

David Groheux | Zendy; Elif Hindié | Zendy; Marc Delord | Zendy; Sylvie Giacchetti | Zendy; Anne-Sophie Hamy | Zendy; C. de Bazelaire | Zendy; Anne de Roquancourt | Zendy; Laëtitia Vercellino | Zendy; MarieElisabeth Toubert | Zendy; Pascal Merlet | Zendy; Marc Espié | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Prognostic Impact of 18FDG-PET-CT Findings in Clinical Stage III and IIB Breast Cancer

Author(s) -

David Groheux,

Elif Hindié,

Marc Delord,

Sylvie Giacchetti,

Anne-Sophie Hamy,

C. de Bazelaire,

Anne de Roquancourt,

Laëtitia Vercellino,

MarieElisabeth Toubert,

Pascal Merlet,

Marc Espié

Publication year - 2012

Publication title -

jnci journal of the national cancer institute

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.797

H-Index - 356

eISSN - 1460-2105

pISSN - 0027-8874

DOI - 10.1093/jnci/djs451

Subject(s) - medicine , breast cancer , stage (stratigraphy) , positron emission tomography , radiology , magnetic resonance imaging , nuclear medicine , mammography , confidence interval , cancer , population , paleontology , environmental health , biology

This study prospectively evaluated the yield of fluorodeoxyglucose positron emission tomography/computed tomography ((18)FDG-PET-CT) in patients with clinical stages II and III breast cancer and the impact of PET-CT results on prognosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research